Structure and Drug Binding of the SARS-CoV-2 Envelope Protein in Phospholipid Bilayers

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the ongoing COVID-19 pandemic. Successful development of vaccines and antivirals against SARS-CoV-2 requires a comprehensive understanding of the essential proteins of the virus. The envelope (E) protein of SARS-C...

Descripción completa

Detalles Bibliográficos
Autores principales: Mandala, Venkata S., McKay, Matthew J., Shcherbakov, Alexander A., Dregni, Aurelio J., Kolocouris, Antonios, Hong, Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523133/
https://www.ncbi.nlm.nih.gov/pubmed/32995764
http://dx.doi.org/10.21203/rs.3.rs-77124/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523133/
https://www.ncbi.nlm.nih.gov/pubmed/32995764
http://dx.doi.org/10.21203/rs.3.rs-77124/v1

Ejemplares similares